Population Pharmacokinetics of Tralokinumab in Adult Subjects With Moderate to Severe Atopic Dermatitis.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 910, doi. 10.1002/cpdd.1113
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 8
Results: 12
1
2
Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single‐dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 987, doi. 10.1002/cpdd.1112
- By:
- Publication type:
- Article
3
Bridging Efficacy of Tofacitinib Immediate‐Release to Extended‐Release Formulations for Treatment of Ulcerative Colitis: Application of a Model‐Informed Drug Development Approach.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 976, doi. 10.1002/cpdd.1106
- By:
- Publication type:
- Article
4
Review of the Chinese Landscape in Phase 1 Clinical Trials for Noncancer Innovative Drugs Over 2015 to 2020.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 903, doi. 10.1002/cpdd.1131
- By:
- Publication type:
- Article
5
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 899, doi. 10.1002/cpdd.830
- Publication type:
- Article
6
Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open‐Label, Randomized, Single‐dose, Crossover Study With Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 949, doi. 10.1002/cpdd.1102
- By:
- Publication type:
- Article
7
First‐in‐Human Evaluation of Oral Denatonium Acetate (ARD‐101), a Potential Bitter Taste Receptor Agonist: A Randomized, Double‐Blind, Placebo‐Controlled Phase 1 Trial in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 997, doi. 10.1002/cpdd.1100
- By:
- Publication type:
- Article
8
Effects of Unsuppressed Endogenous Insulin on Pharmacokinetics and/or Pharmacodynamics of Study Insulin in the Healthy: A Retrospective Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 930, doi. 10.1002/cpdd.1093
- By:
- Publication type:
- Article
9
Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 966, doi. 10.1002/cpdd.1089
- By:
- Publication type:
- Article
10
Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single‐Dose Crossover Studies in Healthy Japanese Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 957, doi. 10.1002/cpdd.1087
- By:
- Publication type:
- Article
11
Clinical Pharmacology of Insulin Aspart Biosimilar GP40071: Pharmacokinetic/Pharmacodynamic Comparability in Hyperinsulinemic Euglycemic Clamp Procedure.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 922, doi. 10.1002/cpdd.1084
- By:
- Publication type:
- Article
12
Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 8, p. 938, doi. 10.1002/cpdd.1081
- By:
- Publication type:
- Article